Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Hormonal imbalances are important in the development of male pattern baldness.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Rare genetic variants in 125 genes are linked to male-pattern hair loss.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

N-acetyl-cysteine improves hair growth and is safe for treating early male hair loss.

Men with male pattern baldness are more likely to have heart disease risk factors, so they should get heart screenings early.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

No link was found between hair patterns and prostate cancer risk in South Indian men.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Curly hair in certain scalp areas can be an early sign of hair loss.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

Men with early-onset hair loss have more heart disease risk factors.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Trichoscopy is useful for diagnosing and monitoring male pattern hair loss.

Durdhuradi Taila may help promote hair growth and reduce hair loss.

Durdhuradi Taila may help promote hair growth and reduce hair loss.

QR678 Neo® improves hair transplant success and hair regrowth.

Genetic testing is crucial for diagnosing rare hair loss disorders.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.